Company: ARTL
Filing Date: 2025-11-12
Form Type: 10-Q
Source: 0001640334-25-002022
Chunk: 56

Company: ARTELO BIOSCIENCES, INC.
Filing Date: 2025-11-12
Form: 10-Q
Item: Part I, Item 2
Chunk 56
---
944 Research and development  1,275   325   950 Total operating expenses  3,089   1,195   1,894 Loss from operations  (3,089 )  (1,195 )  (1,894 )Other income  (31 )  63   (94 )Net loss $(3,120 ) $(1,132 ) $(1,998 )

Our operating expenses for the three months ended September 30, 2025, were $3.1 million compared to $1.2 million for the same period in 2024. The increase in operating expenses for the three months ended September 30, 2025, was primarily the result of increases in professional fees associated with our capital raising efforts and increases in research and development expenditures related to our clinical programs. During the three months ended September 30, 2024, the Company received research and development expenditures tax credits of $1.3 million from the UK Government while the same tax credits in the current year were received during the prior quarter.

Nine months ended September 30, 2025, compared to the nine months ended September 30, 2024

  Nine Months Ended      September 30,    (In thousands) 2025  2024  Change Operating expenses         General and administrative $4,088  $2,779  $1,309 Research and development  4,530   3,517   1,013 Total operating expenses  8,618   6,296   2,322 Loss from operations  (8,618)  (6,296)  (2,322)Other income (expense)  (95)  248   (343)Net loss $(8,713) $(6,048) $(2,665)

 26Table of Contents

Our operating expenses for the nine months ended September 30, 2025, were $8.6 million compared to $6.3 million for the same period in 2024. The increase in operating expenses for the nine months ended September 30, 2025, was primarily the result of increases in professional fees associated with our capital raising efforts, increases in research and development expenditures related to our clinical programs, as well as a decrease in research and development tax credits from the UK Government during the